6
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      The development of hypophosphataemic osteomalacia with myopathy in two patients with HIV infection receiving tenofovir therapy.

      HIV Medicine
      Adenine, adverse effects, analogs & derivatives, Anti-HIV Agents, Antiretroviral Therapy, Highly Active, Fanconi Syndrome, chemically induced, Female, HIV Infections, drug therapy, Humans, Hypophosphatemia, Male, Middle Aged, Muscular Diseases, Organophosphonates, Osteomalacia, Reverse Transcriptase Inhibitors

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          We report two cases in which osteomalacia developed in patients on tenofovir-containing highly active antiretroviral therapy (HAART) in the context of Fanconi syndrome with hypophosphataemia. Bone pain was the presenting feature and myopathy followed in one case. Disability was reversed with withdrawal of the drug and with mineral supplementation. The cases highlight the importance of considering the diagnosis of osteomalacia in patients treated with tenofovir. A possible association with incipient acute renal failure, particularly during nonsteroidal anti-inflammatory drug (NSAID) use, needs further investigation.

          Related collections

          Author and article information

          Comments

          Comment on this article